[Who should be responsible for the treatment of type 2 diabetes?]

Lakartidningen. 2008 Sep;105(36):2432-3.
[Article in Swedish]
No abstract available

MeSH terms

  • Clinical Competence
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diffusion of Innovation
  • Drug Costs
  • Humans
  • Hypoglycemic Agents / economics
  • Hypoglycemic Agents / therapeutic use*
  • Outcome Assessment, Health Care
  • Practice Guidelines as Topic

Substances

  • Hypoglycemic Agents